ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Immutep Ltd
$0.053
Day Range
$0.053 – $0.056
52 Week Range
$0.028 – $0.470
Volume
25.20M
Avg Volume (10D)
24.68M
Market Cap
$78.11M
Price Chart
Market Statistics
Open$0.053
Previous Close$0.053
Day High$0.056
Day Low$0.053
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap78.11M
Shares Outstanding1.47B
Price to Book0.79
Trading Activity
Volume25.20M
Value Traded1.36M
Bid$0.053 × 56,000
Ask$0.055 × 103,334
Performance
1 Day0.00%
5 Day-11.67%
13 Week-86.23%
52 Week-81.40%
YTD-87.23%
Technical Indicators
RSI (14)33.98
50-Day SMA$0.057
200-Day SMA$0.250
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]